The FDA’s regular communications based on reports from its drug safety report database don’t always rattle investors’ cages.

EuroAPI, which is in the midst of a four-year restructuring plan, has sold its Haverhill manufacturing facility in the United Kingdom to Particle Dynamics as part of a share purchase agreement.